Global healthcare company plans new treatment centre in Laois

Express Reporter


Express Reporter

Global healthcare company plans new treatment centre in Laois

3D visualisation of the planned treatment centre. Credit: McLoughlin Architecture.

The Irish branch of an international healthcare provider has plans for a brand new purpose built health centre in Portlaoise.

B Braun Avitum Ireland has applied for planning permission with Laois County Council for a Kidney Dialysis Treatment centre in the Lismard Business Park on the Timahoe Road in Portlaoise.

It is planned that the new building will be a 800 square metre single storey Kidney Dialysis Treatment Centre with connected 49 square metre open service compound area, building and site signage together with 29 car parking spaces.

A decision on the planning application is due at the end of September.

If someone in Laois is in need of Kidney Dialysis Treatment, the nearest centres are currently in Kilkenny or Tullamore.

3D visualisation of the front and inside of the new facility in Portlaoise. Credit: McLoughlin Architecture.

The first purpose built kidney dialysis unit in the country opened in January this year, in Wexford. The Wellstone Wexford Renal Care Centre was the first state of the art building in a new line of renal care centres B Braun is developing.

The same architect, John McLoughlin, who designed the Wexford centre has also designed the new Laois centre. The Wexford facility has the capacity to treat  up to 60 patients a week in 12 treatment bays, three isolation rooms and a self care area for up to three patients. 

B Braun also operates the well-established Wellstone Clinic in Galway. The company is one of the world's largest manufacturers of renal care technology.

B Braun produces and manufactures a range of 5,000 different healthcare products and supplies the global healthcare market with products and systems for anesthesia, intensive care and cardiology. It is a German medical and pharmaceutical device company, which has offices and facilities in more than 50 countries.